Marius Pearson

Oxford PharmaGenesis makes a tremendous splash at the 13th Annual Meeting of ISMPP

Oxford PharmaGenesis joined this year’s International Society for Medical Publication Professionals (ISMPP) Annual Meeting, which attracted more than 550 publication professionals from the pharmaceutical industry, medical communications agencies and publishers.

Oxford PharmaGenesis recognized in 1000 Companies to Inspire Britain report

Oxford PharmaGenesis has been named as one of the ‘1000 Companies to Inspire Britain’ in a report published this week by the London Stock Exchange Group.

Expert insights from Oxford PharmaGenesis at the latest MedComms Brunch Club

At the April MedComms Brunch Club in Oxford, expert insights into the latest trends and industry updates were presented by Dr Chris Winchester, our Managing Director, Dr Paul Farrow, Communications Director, and Saundra Hemmings, Project Manager.

Oxford PharmaGenesis – the view from the Chair at TIPPA's 16th Annual Meeting

Oxford PharmaGenesis Commercial Director Dr Richard White was Chairman of the 16th Annual Meeting of The International Publication Planning Association (TIPPA), held in San Diego, USA on 21–22 February 2017, and provides his insights on the conference.

Oxford PharmaGenesis supports ORCID with a slice of Pi

Teams across the Oxford PharmaGenesis offices have been celebrating Pi Day after more than 100 of us registered with ORCID, joining a community of over 3.14 million people who share the vision of transparency and trust in research and innovation.

Oxford PharmaGenesis shares its social media expertise

As a leading healthcare communications company and a proud member of the Reciprocate network, Oxford PharmaGenesis takes its corporate social responsibilities very seriously.

Rare Disease Day 2017: focus on research

Today, 28 February 2017, marks the 10th international Rare Disease Day and this year’s theme is ‘Research‘.

Your questions on cancer answered on #worldcancerday

To mark World Cancer Day, we asked everyone at Oxford PharmaGenesis for their burning questions about cancer. We then asked our Oncology team to give their views on the most frequently asked questions – here is what they said.

Stakeholders meet to discuss leadership opportunities for pharma in the publishing of scientific research

Can the pharmaceutical industry help to advance the model for publishing of scientific research? This question has assumed greater importance as other funders have started to flex their muscles, introducing open access policies and even their own publishing platforms (e.g. Royal Society Open Science, Wellcome Open Research), but stringent regulation and widespread mistrust of open […]

Oxford PharmaGenesis knitters take part in The Big Knit for Age UK

A group of budding knitters from the Oxford PharmaGenesis Oxford office answered the plea from Innocent to create knitted hats for their smoothie drinks by knitting more than 80 amazing hats!